Docusign (NASDAQ:DOCU – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.95 by $0.06, FiscalAI reports. The company had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.57% and a return on equity of 15.02%. Docusign’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.86 earnings per share.
Docusign Stock Performance
Docusign stock opened at $47.54 on Wednesday. The firm’s fifty day moving average price is $51.11 and its 200-day moving average price is $64.46. The stock has a market cap of $9.52 billion, a P/E ratio of 33.24, a price-to-earnings-growth ratio of 2.04 and a beta of 1.03. Docusign has a fifty-two week low of $40.16 and a fifty-two week high of $94.67.
Insider Activity at Docusign
In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of the firm’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the sale, the chief executive officer owned 142,261 shares in the company, valued at $9,901,365.60. This trade represents a 15.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CRO Paula Hansen sold 6,000 shares of Docusign stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $67.05, for a total value of $402,300.00. Following the sale, the executive directly owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 51,477 shares of company stock valued at $3,521,607 over the last ninety days. 1.66% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Docusign
Wall Street Analysts Forecast Growth
Several research analysts have commented on the stock. Royal Bank Of Canada cut their price target on shares of Docusign from $95.00 to $70.00 and set a “sector perform” rating for the company in a report on Monday, January 5th. BTIG Research lowered their price objective on Docusign from $88.00 to $70.00 and set a “buy” rating on the stock in a research report on Wednesday, February 18th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Tuesday, March 10th. UBS Group reduced their target price on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Finally, Wedbush decreased their target price on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat, Docusign currently has a consensus rating of “Hold” and an average price target of $78.80.
Check Out Our Latest Stock Report on DOCU
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q4 earnings and revenue beat consensus (EPS $1.01 vs. $0.95 estimate), showing upside to recent expectations — this is the primary near‑term catalyst supporting the stock. DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
- Positive Sentiment: Company raised its share buyback authorization by $2.0 billion — a direct capital‑allocation move that supports EPS and can buoy the stock. Docusign Announces Fourth Quarter and Fiscal Year 2026 Financial Results; Announces $2.0 Billion Increase to Share Repurchase Program
- Positive Sentiment: Board addition of an AI‑focused independent director and ongoing AI product integrations are being viewed as strategic positives that could drive future subscription expansion beyond e‑signatures. The Bull Case For DocuSign (DOCU) Could Change Following New AI-Focused Director Appointment – Learn Why
- Neutral Sentiment: Analysts and previews focused on key Q4 metrics and guidance comparisons; these items will matter for next‑quarter sentiment but are read as routine post‑earnings analysis. DocuSign (DOCU) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Neutral Sentiment: Marketwide drivers (Fed/FOMC meeting, macro data, big‑tech events) are creating broader volatility that could amplify DOCU moves short‑term. Markets Wait for Fed’s FOMC Meeting
- Negative Sentiment: Bearish commentary warns DOCU remains vulnerable after a steep multi‑month pullback; some analysts flag valuation and downside risk if execution or guidance disappoints. DocuSign stock price at risk of a steep crash after earnings on March 17
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
